Marea Therapeutics Enrolls First Participant in Phase 1 Clinical Study Evaluating MAR002 for Acromegaly

Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results

ARTBIO Appoints Four New Board Members, Co-Founder Transitions to Technical Advisory Board Role

Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update